Complementary effect of Roe's congenital heart disease treatment compared to Wade's

Published Date: 16 Feb 2023

As more states repeal or restrict abortion laws, the number of patients, the number of workers needed, and the cost of heart disease will increase. How should hospitals and policy makers prepare?

Read Full News

Latest News

Can Nurses Safely Replace Physicians in Some Roles?

An 82-trial Cochrane review finds little difference in mortality, quality of life, or safety when nurses substitute for physicians — but outcomes vary widely by specialty and model.

Dialysis Patients With Diabetes Face High Amputation Burden

Patients undergoing dialysis, especially those with diabetes as the primary renal disease, face a high risk for lower limb amputation and mortality after amputation, a cohort study finds.

Less Weight Regain, More Health Loss after Stopping GLP-1s?

Patients on GLP-1s who stop taking the drugs may maintain 25% of their weight loss at one year, but whether their regained weight is mainly fat or lean mass isn’t clear.

Societies Issue Pharmacologic Obesity Management Guidance

The Obesity Society, Obesity Medicine Association, and the Obesity Action Coalition have published joint guidance incorporating patient input.

Smartwatch Hypertension Alerts Shouldn’t Replace Screening

Receiving an alert increased the probability of undiagnosed hypertension, but absence of an alert did not reliably rule it out and should not replace cuff-based screening.

Can Drug-Eluting Balloons Challenge Stents in STEMI?

Proponents argue drug-eluting balloons avoid permanent implants and may shorten dual antiplatelet therapy, whereas critics warn of vessel dissection and the need for bailout stenting.

Todays Updates

Biomarker Flags 10-Fold Recurrence Risk in Testicular Cancer

MiR-371 isn’t ready for the clinic yet, but it is ready for interventional trials to see if it can refine adjuvant chemotherapy decisions in stage I testicular cancer.

FDA Approves New Drug Combo for RR Multiple Myeloma

Teclistamab plus daratumumab and hyaluronidase-fihj is approved for relapsed or refractory MM after one prior line of therapy, including a proteasome inhibitor and immunomodulatory agent.

Todays Updates

Biomarker Flags 10-Fold Recurrence Risk in Testicular Cancer

MiR-371 isn’t ready for the clinic yet, but it is ready for interventional trials to see if it can refine adjuvant chemotherapy decisions in stage I testicular cancer.

FDA Approves New Drug Combo for RR Multiple Myeloma

Teclistamab plus daratumumab and hyaluronidase-fihj is approved for relapsed or refractory MM after one prior line of therapy, including a proteasome inhibitor and immunomodulatory agent.

Latest News

An 82-trial Cochrane review finds little difference in mortality, quality of life, or safety when nurses substitute for physicians — but outcomes vary widely by specialty and model.

Patients undergoing dialysis, especially those with diabetes as the primary renal disease, face a high risk for lower limb amputation and mortality after amputation, a cohort study finds.

Patients on GLP-1s who stop taking the drugs may maintain 25% of their weight loss at one year, but whether their regained weight is mainly fat or lean mass isn’t clear.

The Obesity Society, Obesity Medicine Association, and the Obesity Action Coalition have published joint guidance incorporating patient input.

Receiving an alert increased the probability of undiagnosed hypertension, but absence of an alert did not reliably rule it out and should not replace cuff-based screening.

Proponents argue drug-eluting balloons avoid permanent implants and may shorten dual antiplatelet therapy, whereas critics warn of vessel dissection and the need for bailout stenting.

News All Time

EMA Rejects Drugs for Rett Syndrome, Schizophrenia

Daybue was turned down for Rett syndrome, and Iloperidone for schizophrenia and bipolar I, with safety and benefit-risk concerns cited in both cases.

Resuscitation’s Ethical Dilemma: Rethink Epinephrine Use

Epinephrine improves ROSC in cardiac arrest but does not increase favorable neurologic recovery, raising ethical and guideline questions for clinicians.

Bariatric Surgery Beats GLP-1s for Heart Protection in T2D

A meta-analysis of 11 studies involving over 19,000 patients with T2D and obesity shows that bariatric surgery provides greater cardiovascular protection and mortality reduction than GLP-1 drugs.

Tenecteplase May Help Stroke Recovery Past 4.5-Hour Window

Some patients with a common type of stroke benefit from a clot-busting drug given between 4.5 and 24 hours after symptoms emerged, according to a new study.

How Leptin Became the Sexiest Thing in Science (Again)

Thirty years after its discovery, scientists are eyeing leptin with renewed interest, for everything from weight loss drug cocktails to novel treatments for rare diseases and anorexia.

Alarming Rise in CVD Deaths Among US Adults With Obesity

Cardiovascular mortality among US adults with obesity tripled from 1999 to 2023, with persistent and widening disparities across certain sociodemographic and geographic groups.

Younger Women Face Increase in Heart Disease Risk

A new AHA scientific statement warns that cardiovascular disease is rising fastest among younger women, with stroke rates in those aged 20-44 years projected to nearly double by 2050.

Bariatric Surgery Boosts Metabolic Health in T1D and Obesity

Metabolic bariatric surgery is linked to significant weight loss, lower insulin requirements, and improvements in glycaemic control in adults with type 1 diabetes and obesity.

Pregnancy Hypertension Timing Tied to Long-term Hypertension

Hypertensive disorders of pregnancy, whether detected before, during, or after childbirth, are linked to an increased risk of developing high blood pressure 2-7 years after delivery.

Do Higher Inflammatory Marker Levels Matter After Stroke?

After stroke, atrial fibrillation is linked to higher inflammation beyond the acute phase; higher high-sensitivity C-reactive protein levels are tied to a risk for major events, not recurrent stroke.

How Nighttime Light Quietly Became a Serious Health Threat

More and more research links nighttime light exposure to negative effects on cardiac, metabolic, cognitive, and mental health. What makes it so harmful?

Q&A: AMA President’s Health Crisis Informs View of US System

Bobby Mukkamala, MD, knew the facts and statistics. But a brain tumor truly opened his eyes.

Low Coronary Plaque Burden May Not Equal Low Risk in Women

Women who present with chest pain or angina may be at greater risk for heart attack, hospitalization, and death than men with the same plaque burden.

Youth With Developmental Disabilities Face Higher Mortality

Youth and young adults with autism spectrum disorder, intellectual disability, or cerebral palsy experience higher mortality than the general population; causes of death vary widely.

Alexei Navalny’s Death: Epibatidine Poisoning Suspected

European labs report epibatidine in samples from Alexei Navalny, suggesting poisoning. No public autopsy data; clinicians stress critical supportive care for such toxins.

AI Assistant Offers Promise for Patients After HFrEF

A virtual assistant powered by AI supervised by a cardiologist can offer guideline-directed medical therapy optimization after hospitalization for heart failure with reduced ejection fraction.

Recommended News For You

To refute accusations that it failed to issue a cancer warning, Roundup's maker is asking lawmakers for assistance.

Nanoparticle vaccine prevents multiple cancers and stops metastasis in mice

Utilizing cerium/lanthanum-134 to improve cancer detection and treatment.

Imetelstat for MDS-relateret anemia er godkendt af Food and Drug Administrations panel.

A person's susceptibility to papillary thyroid cancer may be determined by variations in telomere lengthening genes.

Alkem introduces cetuximab under the trade name Cetuxa in India.

Could AI plus lasers help catch very early breast cancers?

Recommended Articles For You

The Mysterious World of Petechiae: Exploring Causes and Treatments 

Advancing Oncology Careers with Education, Workflow Tools, and Clinical Resources 

Ultimate Guide to Oncology Services in the USA 

Seeing the Unseen: Examining Chancroid Through Images 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Survival improved with lobectomy, segmentectomy in early non-small cell lung cancer

2.

Which women need more than mammograms for breast cancer screening?

3.

Fake Cancer Drugs; Let's Talk About Sex; Reducing Cancer-Related Fatigue

4.

NEJM: Pirtobrutinib is effective in CLL patients who have received prior BTK inhibitor therapy.

5.

In NPM1-mutated acute myeloid leukemia, MRD Correlates with Allo-Transplant Benefit.

1.

Exploring the Potential of Xospata: A New Frontier in Cancer Treatment

2.

All You Need To Know About Partial Thromboplastin Time (PTT) Test

3.

MMA Embolization in Chronic Subdural Hematoma: Evidence, Outcomes, and Gaps

4.

Next-Generation Sequencing in Oncology: Unlocking the Future of Precision Medicine

5.

Mastering Prostate Cancer Care: CME, Certification, Digital Tools, and Evidence-Based Strategies

1.

International Lung Cancer Congress®

2.

Future NRG Oncology Meeting

3.

Genito-Urinary Oncology Summit 2026

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Navigating the Complexities of Ph Negative ALL - Part XI

2.

Current Scenario of Cancer- An Overview of The Incidence of Cancer in Men

3.

Beyond the Mutation: Addressing the Unmet Needs in ALK-Positive NSCLC

4.

From Relapse to Remission : Chasing the Invisible and Redefining Long-Term Survival in Adult R/R B-Cell ALL

5.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot